CEFOTETAN Drug Patent Profile
Which patents cover Cefotetan, and what generic alternatives are available?
Cefotetan is a drug marketed by Fresenius Kabi Usa, Hikma, West-ward Pharm Corp, and B Braun. and is included in five NDAs.
The generic ingredient in CEFOTETAN is cefotetan disodium. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the cefotetan disodium profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CEFOTETAN?
- What are the global sales for CEFOTETAN?
- What is Average Wholesale Price for CEFOTETAN?
Summary for CEFOTETAN
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 5 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 51 |
| Clinical Trials: | 7 |
| Patent Applications: | 7,095 |
| Drug Prices: | Drug price information for CEFOTETAN |
| DailyMed Link: | CEFOTETAN at DailyMed |
Recent Clinical Trials for CEFOTETAN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Oregon Health and Science University | PHASE2 |
| Federal University of São Paulo | Phase 4 |
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Pharmacology for CEFOTETAN
| Drug Class | Cephalosporin Antibacterial |


